Urology

Ambu A/S is the global market leader in single-use endoscopy, a category the company created in 2009. The company manufactures and distributes a comprehensive portfolio of single-use (disposable) endoscopic devices and airway management solutions for hospitals, emergency care settings, and training environments. Core product lines include the aScope™ family of flexible endoscopes for pulmonology (bronchoscopy), gastroenterology (gastroscopy), urology (cystoscopy), and ENT applications, as well as rigid and semi-rigid visualization systems. Specialty products include the aScope™ 5 Broncho with color-coded sizing, aScope™ Gastro Large for therapeutic gastroscopy, aScope™ 5 Cysto HD for urology with superior image quality, and the aScope™ 4 Broncho Sampler Set for improved BAL/BW workflow. The company also offers airway management solutions, including the SureSight™ Connect video laryngoscope for intubation and upper airway visualization. Ambu serves multiple clinical specialties: pulmonology, ENT, gastroenterology, urology, neurology, cardiology, and anesthesia. The company has received recognition for technology innovation, earning the 2025 Frost & Sullivan Technology Innovation Leadership Recognition in the European single-use endoscopy industry. All products are single-use, sterile, and designed to eliminate cross-contamination risks associated with reusable instruments. Ambu operates globally with local representatives and maintains both hospital and emergency/training market segments.

ADM Tronics Unlimited, Inc. is a full-service electronic medical device innovation firm specializing in design, engineering, development, and manufacturing of diagnostic and therapeutic medical technologies. The company operates an FDA-regulated facility with robust quality control and manufacturing capabilities, bringing medical devices from concept through production. ADMT maintains extensive regulatory expertise across FDA, GMP, CE, ISO 13485, CMDCAS, ETL, and UL standards. The company has developed proprietary non-invasive electrotherapy medical devices spanning multiple therapeutic areas including audiology, physical medicine, wound therapy, neurology, and urology. Key proprietary products include Aurex (tinnitus treatment), Sonotron (non-invasive RF electrotherapy for pain management), and Vet-Sonotron (veterinary non-invasive therapy). ADMT also manufactures specialty water-based formulations and products through subsidiaries including Aqua Based Technologies (primers, adhesives, coatings), Antistatic Industries (static-safe materials and StaticPaint®), and Pros-Aide® (medical prosthetic and special effects adhesive). The company is publicly traded on the OTCQB marketplace under symbol ADMT and has a multi-generational heritage of innovation in electronics and electromechanical design.

RetroPerc, Inc. manufactures specialized equipment and procedural kits for percutaneous nephrolithotomy (PCNL) and nephrostomy creation. The company's core product is the RetroPerc system, a device designed to improve renal protection and precision during percutaneous nephrostomy procedures by enabling alignment of the nephrostomy sheath with the infundibulum along the three-dimensional (X-Y-Z) axis. The system includes a puncture wire assembly with tip protection sheath, coaxial exchange catheter, 0.035" nephrostomy wire, balloon dilator, and nephrostomy sheath. RetroPerc's procedural approach positions a flexible ureteroscope in the selected infundibulum with the puncture apparatus advancing through the same anatomical pathway, thereby minimizing renal trauma compared to traditional approaches. The system is designed for modern urology practices and provides enhanced visualization during PCNL procedures. Products include puncture apparatus kits with pin-wise lock mechanisms, exchange catheters, and associated dilation and sheath components used in retrograde-access percutaneous renal surgery. The company serves urologists and urology-focused surgical centers performing stone management and percutaneous renal intervention procedures.

Aulea Medical manufactures the Veloxion all-in-one system, a single-use, integrated platform for benign prostatic hyperplasia (BPH) treatment via transurethral resection of the prostate (TURP). The system combines fluid management, video imaging, and radiofrequency energy generation in a single console to streamline urology workflows. Key clinical innovations include automated intravesical pressure monitoring and control, motorized plasma cutting technology, multi-directional resection capability, and immediate tissue evacuation to maintain visualization. The Veloxion is designed to reduce BPH treatment time to approximately 20 minutes compared to standard TURP (60 minutes), enable same-day procedures in ambulatory surgery centers for prostate glands ranging 30–200g, and eliminate infection risk and cross-contamination through single-use endoscopic devices. The system requires minimal setup and teardown, reducing procedure time and cost of ownership. Aulea targets urology departments, ambulatory surgery centers, and specialty urology practices. The company emphasizes safety (pressure management to prevent bladder perforation, sterile single-use design), simplicity (plug-and-play console, automated fluid evacuation), and procedural efficiency. Manufacturing capabilities include single-use device fabrication and integrated RF energy generation systems.

Calyxo, Inc. is a medical device company specializing in minimally invasive urological surgery, with a focus on kidney stone management. The company manufactures the CVAC® System, an integrated ureteroscopic platform designed for complete stone clearance. The CVAC System combines multiple capabilities in a single device: laser lithotripsy, microjet irrigation, dynamic aspiration, and stone collection. The proprietary SURE Procedure (Steerable Ureteroscopic Renal Evacuation) is a treatment protocol performed exclusively with the CVAC System that uses laser lithotripsy, irrigation, and vacuum aspiration to achieve superior stone clearance outcomes. Clinical evidence from a randomized controlled trial demonstrates 97% stone clearance rates, superior to standard ureteroscopy. The company targets urology departments and ambulatory surgery centers performing endoscopic stone treatment. Calyxo positions the CVAC System as a game-changing innovation in kidney stone care, reducing procedural complexity by integrating multiple treatment modalities. The device appears to be FDA-cleared for clinical use (regulatory designation MAC00071.B referenced on homepage). The company is actively recruiting clinical staff and maintaining an active clinical development program with published outcome data.

Scivita Medical Technology Co., Ltd. is a minimally invasive surgical device manufacturer headquartered in Suzhou, China. The company designs and manufactures single-use and reusable endoscopic instruments and systems for gynecology, urology, orthopedics, thoracic surgery, ENT, general surgery, respiratory, and gastroenterology applications. Product portfolio includes single-use video arthroscopes, transforaminal endoscopes, flexible and semi-flexible hysteroscopes, rigid and flexible cystoscopes, and ureteroscopes. The company also produces the Omni Power System for minimally invasive surgical procedures and operates a Dual-scope Platform integrating rigid and flexible endoscopy. Scivita maintains a CNAS-accredited testing center for full-chain endoscope validation and quality assurance. The company serves global markets through international presence and clinical education programs. Manufacturing capabilities encompass design, assembly, quality testing, and sterilization of single-use surgical instruments and integrated endoscopic systems. The company has demonstrated growth through new product launches and international conference presentations, including recent debuts at major urology and surgical conferences.

KARL STORZ is a global medical technology manufacturer specializing in endoscopic visualization systems, minimally invasive surgical instruments, and operating room integration solutions. The company develops and manufactures rigid and flexible endoscopes, laparoscopic and arthroscopic equipment, video laryngoscopes for airway management, and specialized instruments for general and visceral surgery, urology, otorhinolaryngology, gynecology, and gastroenterology. KARL STORZ offers comprehensive imaging solutions including camera systems, light sources, and monitors designed for integration into surgical workflows. The product portfolio exceeds 15,000 items spanning telescopes, instruments, electrosurgical devices, and OR integration systems. The company serves hospitals, surgical centers, and specialized practices globally. KARL STORZ provides extensive customer support including product manuals, online catalogs, repair and maintenance services, and training programs through dedicated training centers. The company has pioneered video laryngoscope technology and maintains leadership in endoscopic visualization and laparoscopic surgery solutions. All products are manufactured to medical device standards including FDA clearance and international regulatory compliance. The organization partners with leading physicians, universities, and research institutes to identify clinical trends and translate them into innovative surgical solutions.

Optical Integrity, Inc. is a pioneering medical device manufacturer founded in 2000, specializing in laser fiber technologies for surgical applications. The company serves procedure-driven fields including urology, vascular surgery, and ENT (otorhinolaryngology), providing advanced fiber-optic systems and tools for minimally invasive surgical procedures. Their product portfolio includes laser fibers and related optical devices designed to enhance surgical precision and cost-effectiveness for physicians globally. The company manufactures under strict regulatory oversight, including FDA, European MDD, and Health Canada compliance. Optical Integrity holds ISO 13485:2016 certification for quality management systems and maintains EC certification, demonstrating adherence to international medical device standards. The company emphasizes commitment to quality assurance, customer satisfaction, and timely delivery of surgical-grade optical instruments to healthcare practitioners worldwide.

Augusta Medical Systems LLC manufactures and distributes vacuum therapy systems for erectile dysfunction treatment. The company's primary product line is SomaTherapy-ED, a non-invasive vacuum erection device platform designed for patients seeking alternatives to pharmaceutical or invasive treatments. Products include both manual and battery-operated negative pressure devices paired with customizable tension ring systems. The SomaTherapy-OTC Manual and Premium systems are available over-the-counter; the SoMAerectStf and SoMAerectStf Plus systems offer additional cylinder inserts and expanded tension ring options. Each system includes accessories such as sizing adapters, lubricant, and carrying cases. The company reports a 90%+ success rate and positions vacuum therapy as suitable for use alone or in combination with oral medications, injection therapy, or other ED treatments. Augusta Medical Systems operates both direct-to-consumer and professional channels, offering physician wholesale and affiliate programs. The company serves patients recovering from prostate surgery, those with diabetes-related ED, and individuals seeking cost-effective alternatives to pharmaceutical or clinical interventions. Products are priced between $199 and $350 retail. The company maintains customer support and educational resources including instructional videos, guides, and testimonials. No explicit FDA, ISO, or regulatory certifications are referenced on the site, though vacuum therapy devices are generally classified as OTC medical devices in the US.

Ningbo Wise Optomech Technology Corporation (trading as OTU Medical) designs and manufactures single-use digital flexible endoscopes and visualization systems for minimally invasive diagnostic and therapeutic procedures. The company's primary product line is the WiScope® Single-Use Digital Flexible Cystoscope (C311 Series), a disposable urological endoscope system designed for cystoscopy and urology procedures. OTU Medical serves multiple medical specialties including Urology, Gastroenterology, Pulmonology, Gynecology, and ENT (Otorhinolaryngology), indicating a platform approach to single-use endoscopic instrumentation across multiple clinical domains. The company manufactures image processors and visualization equipment to complement endoscopic instruments. Product lines are segmented by specialty (Urology, Gastroenterology, Pulmonology, Gynecology, ENT) with co-branding partnerships available. The company exhibits at major international medical conferences including AUA (American Urological Association) and EAU (European Association of Urology), indicating active engagement in the US and European urology markets. Manufacturing and technology capabilities center on digital single-use endoscope design, optics integration, and image processing systems. No specific FDA clearance status, ISO certification details, or manufacturing location details are available from the website content provided.

Urocare Products, Inc. is a manufacturer of urological medical devices and drainage systems specializing in innovative urine collection and catheter care products. Founded in 1975, the company has developed a comprehensive line of urinary drainage solutions including reusable latex leg bags, disposable vinyl leg bags, and urinary drainage bottles. The company's flagship innovation is the patented Little Red Valve®, a self-cleaning anti-reflux valve designed to prevent urine backflow, reduce bladder distention risk, and minimize infection incidence associated with standard drainage products. Urocare manufactures these products as the sole provider of devices incorporating the Little Red Valve® technology. The company serves healthcare providers and patients in the United States and maintains international distribution. Products are designed with emphasis on durability, safety, and ease of use based on years of research, development, customer feedback, and engineering refinement. Urocare's offerings are recognized for practical clinical benefits in managing urinary incontinence and catheter-dependent patients, particularly in home care and long-term care settings.

PUSEN USA manufactures and distributes single-use ureteroscopes, cystoscopes, and HD image processors for urology and endoscopic procedures. The company specializes in disposable flexible ureteroscopes designed for stone management with patented features that reduce patient trauma, minimize need for ureteral stenting, and decrease post-operative pain. Their single-use cystoscopes are engineered for high-quality optics, rapid setup, and point-of-care diagnostic capabilities in office-based and hospital settings. PUSEN USA's HD image processors deliver superior visualization for enhanced clinical decision-making. The product line emphasizes ergonomic design, ease of use, and improved workflow efficiency for busy urology practices. The company markets to urologists, urology centers, and hospital systems across the United States. Reimbursement information and clinical testimonials from leading urology practitioners (Dr. Stephen Weiss, Advanced Urology Institute; Dr. Christopher J. DiBlasio) support adoption. PUSEN USA operates a US-based sales organization with national distribution and customer support infrastructure.

InnoCare Urologics manufactures the Egress AutoValve™, the first FDA-cleared urinary safety catheter designed with an automatic deflation mechanism to prevent patient injury from catheter pullout. The device is engineered to look and feel identical to standard Foley catheters, requiring no additional training or workflow changes for clinical staff. The innovation addresses a significant clinical problem: approximately 700,000 catheters are pulled out annually with balloons inflated, resulting in approximately $4.5 billion in annual treatment costs. The Egress AutoValve™ integrates a secondary deflation mechanism into the inflation lumen that remains inactive until external pulling force above a predetermined threshold is applied, at which point it automatically deflates the balloon prior to forced removal. The catheter is particularly designed for high-risk patient populations including those with cognitive impairments (dementia, delirium), ICU patients, and post-surgical patients. InnoCare received FDA clearance under a newly created product classification code (SCT) recognizing Foley catheters and accessories with additional safety features—the first device cleared under this category. The company received the 2025 American Urological Association (AUA) Innovation Award. The device seamlessly integrates into existing clinical practice without requiring new supplies or preparation protocols.

Fine Surgical Instruments, Inc. is a leading manufacturer and distributor of precision surgical instruments based in Hempstead, New York. The company supplies the global medical industry with an extensive range of high-quality surgical instruments across multiple specialties. Their comprehensive product portfolio includes diagnostic instruments, scalpels, scissors, forceps, needle holders, retractors, suturing instruments, and specialty tools for ophthalmology, ENT, gynecology, obstetrics, orthopedics, cardiology, urology, thoracic, neurosurgery, and bariatric procedures. Fine Surgical serves hospitals, surgical centers, and medical practitioners worldwide, offering both standard surgical instruments and specialized equipment for various surgical disciplines. The company provides an online catalog for procurement efficiency and maintains dedicated domestic and international sales teams.

STORZ MEDICAL AG is a Swiss-based world leader in non-invasive shock wave therapy systems and lithotripters, established in 1987. The company designs and manufactures high-precision medical devices for Extracorporeal Shock Wave Lithotripsy (SWL), Extracorporeal Shock Wave Therapy (ESWT), and Extracorporeal Magnetotransduction Therapy (EMTT). Its products serve multiple clinical disciplines including urology (kidney and ureteral stone treatment), orthopedics and sports medicine (musculoskeletal disorders), cardiology (Cardiac Shock Wave Therapy for myocardial revascularization), neurology (Transcranial Pulse Stimulation for Alzheimer's disease), dermatology, and veterinary medicine. The MODULITH® SLX-F2 is FDA-approved for pediatric kidney stone therapy in the USA. With over 100,000 installed systems in 130+ countries, STORZ MEDICAL offers both focused and radial shock wave modalities, complemented by vibration therapy (V-ACTOR®) and integrated software solutions. All devices carry CE, FDA, and MDSAP certifications.

QLRAD is a medical device manufacturer specializing in the development, design, and assembly of innovative products for radiotherapy and urology applications. The company serves over 100 healthcare organizations worldwide with a focus on precision medical devices that support diagnostic and therapeutic workflows. Primary product lines include endorectal balloons (RectalPro) designed for reproducible positioning and patient comfort in radiotherapy procedures, goldmarkers and fiducial needles used in image-guided interventions and brachytherapy, and breast immobilization devices (IMF Breast Wedge) utilized in radiation oncology positioning and treatment planning. QLRAD maintains manufacturing and distribution capabilities across multiple regions including the USA, Cyprus (International headquarters), and the Netherlands, ensuring global accessibility and compliance with regional regulatory requirements. The company demonstrates clinical engagement through participation in major professional conferences (ASRT, AAPM) and publication of clinical data supporting product efficacy and safety. Products are designed to enhance procedural accuracy, reproducibility, and patient tolerability in specialized medical applications.

Rigicon® Innovative Urological Solutions is a global manufacturer of advanced prosthetic urology solutions, specializing in penile implants, testicular prostheses, and related surgical instruments. The company designs and markets innovative medical devices for pelvic urology, including the Rigicon® Infla10® Three-piece Inflatable Penile Prosthesis (known for strong revision survival rates), malleable penile prostheses, and the HL-LEVINE Combo Prosthesis Tool for penile implant surgery. Rigicon also manufactures Artificial Urinary Sphincter (AUS) systems and testicular implants (both saline-filled and firm variants). The company provides comprehensive support to healthcare professionals through clinical studies, surgical training materials, product specifications, and technical documentation. Patient resources include recovery guides, educational materials on treatment options, and expert care locator services. Rigicon serves a global customer base across multiple regions including North America, Europe, Asia-Pacific, Middle East/North Africa, and Latin America, positioning itself as a trusted partner in advancing prosthetic urology practices worldwide.

Herniamesh® SRL is an Italian manufacturer of surgical meshes and prostheses founded in 1995 by surgeon Dr. Ermanno Trabucco. The company specializes in CE-marked and FDA 510(K)-approved medical devices for inguinal and abdominal wall hernia repair, as well as female urinary incontinence and pelvic floor dysfunction treatment. The product portfolio includes customizable flat meshes for open surgery (non-absorbable monofilament polypropylene), pre-shaped suture-less meshes, and patented flagship products including Hybridmesh (slow partially absorbable mesh using quadraxial technology for inguinal hernia repair) and Relimesh (thin, pliable intraperitoneal prosthesis for ventral hernia). All devices are manufactured under ISO 13485:2021 certified quality management systems. Herniamesh maintains a global distribution network across 33 licensed countries, supported by a trained sales force and surgeon training workshops in collaboration with key opinion leaders.

HealthTronics is a specialized urology equipment and service provider serving over 1,500 physicians and 2,000 healthcare facilities nationwide. The company specializes in lithotripsy (shockwave), laser, and ureteroscopy solutions for kidney stone disease management. HealthTronics offers a comprehensive stone management platform including extracorporeal shock wave lithotripsy (ESWL) systems, laser lithotripsy equipment, single-use ureteroscopes, and consumables for ureteroscopic procedures. The company operates under a physician investment model, providing joint venture and partnership solutions to urologists and hospital systems seeking capital-efficient kidney stone treatment programs. Core service capabilities include equipment rental, maintenance, repair, and technical support through field engineers deployed nationally. HealthTronics emphasizes operational management of medical technology, quality assurance, compliance support, and process optimization. The company positions itself as both a product supplier and operational solutions provider, enabling practices and facilities to improve financial performance, patient satisfaction, and clinical focus while reducing system costs. Customers include independent urology practices, health systems, and ASCs requiring reliable access to stone management equipment with integrated technical and administrative support.

Accurate Surgical & Scientific Instruments Corp. (ASSI) is a leading manufacturer of precision surgical instruments for specialized surgical disciplines. With nearly four decades of industry experience, ASSI supplies a comprehensive range of expertly crafted instruments including bipolar and monopolar forceps, scissors, needle holders, retractors, microvascular clamps, and specialty tools for microsurgery, hand surgery, neurosurgery, plastic and reconstructive surgery, ophthalmology, ENT, urology, and vascular surgery. The company emphasizes precision engineering, quality materials (stainless steel, titanium, insulated variants), and customer service. Products span electrosurgical instruments, bone and soft tissue surgery tools, and specialized microsurgical equipment. ASSI operates manufacturing and distribution facilities on both US coasts with B2B direct sales to hospitals, surgical centers, and medical professionals.

Focalyx is a MedTech company specializing in precision diagnosis and treatment of prostate cancer through AI-driven software and minimally invasive procedural guidance. The Focalyx Fusion platform provides computer-assisted surgical planning and real-time intraoperative guidance for focal prostate therapy, enabling targeted ablation of cancerous lesions while preserving healthy prostate tissue and function. The platform combines advanced imaging analysis with GPS-like navigation to deliver office-based, outpatient prostate cancer treatment with minimal hospitalization, fast recovery, and improved preservation of urinary and sexual function. Clinical outcomes demonstrate 86% cancer-free status at 5 years with 95% urinary improvement and 88% erectile retention rates across 6,000+ procedures performed globally.

Embolx Inc. is a medical device company specializing in advanced microcatheters for arterial embolization procedures. As a subsidiary of Edwards Lifesciences, the company develops innovative solutions for interventional oncology and related specialties, including treatments for cancerous tumors, benign prostatic hyperplasia (BPH), and uterine fibroids. The flagship product, Sniper® Balloon Occlusion Microcatheter, enables precise delivery of embolic agents with controlled blood flow pressure management. The latest generation, Sniper G3 (launched July 2025), offers improved efficiency and ease of use for healthcare providers. Embolx products are available in US and European markets and serve interventional radiologists and specialists performing minimally invasive embolization procedures.

Thermidas Oy is a Finnish health technology company established in 2008, specializing in CE-approved and FDA-cleared infrared (IR) thermal imaging systems for medical diagnostics and monitoring. The company's flagship solution is the IRT-384 Tablet, an all-in-one portable thermal imaging system with integrated VistaClinic software for real-time temperature analysis and long-term treatment evaluation. Thermidas' non-invasive, radiation-free thermal imaging technology detects asymmetric body temperatures indicating inflammation, circulatory issues, and potential ulcerations. Primary clinical applications include diabetic foot ulcer prevention and monitoring, pressure injury assessment, physiotherapy evaluation, and geriatric care. The company also offers the ThIR-A615 workstation system for hospital and clinic environments, and is developing telehealth solutions for remote home monitoring. Thermidas' intuitive software, developed in partnership with university hospitals and experienced clinicians, enables healthcare professionals to quickly locate temperature anomalies and generate comprehensive diagnostic reports. The technology is currently used by major European hospitals and research institutions including NHS, King's College London, and Finnish university hospitals.

Morphic Medical is a Boston-based MedTech company founded in 2003 specializing in innovative, minimally invasive device therapies for type 2 diabetes and obesity. The company's flagship product, RESET® therapy, is an endoscopically delivered device designed to address the underlying metabolic causes of type 2 diabetes and weight gain. RESET targets patients underserved by traditional pharmaceuticals and injections who are unsuitable for bariatric surgery, aiming to reduce HbA1c levels and body weight while improving glycemic control and cardiovascular risk profile. Currently investigational in the United States, RESET is undergoing clinical validation through the STEP-1 trial. Morphic Medical bridges the therapeutic gap between medical management and surgical intervention, offering a non-surgical alternative that leverages endoscopic delivery mechanisms to achieve durable metabolic benefits.

Rexmed Health is a medical device original equipment manufacturer (OEM) and contract manufacturer based in El Paso, Texas, with a manufacturing plant in Ciudad Juarez, Mexico. The company specializes in designing, engineering, and manufacturing medical devices for parenteral delivery, infusion therapy, and specialty applications. With over 20 years of experience, Rexmed manufactures products serving ophthalmic surgery, urology, parenteral nutrition, IV therapy, cardiology, airway management, and pain management sectors. Core manufacturing capabilities include fluid delivery sets, infusion pump systems, parenteral bags and configurations, and surgical dispensing coils, produced in certified clean rooms (Class 8 environment). The company holds FDA approval, COFEPRIS (Mexican regulatory) certification, CT-PAT customs certification, and operates under cGMP compliance. Rexmed provides integrated services including process validation (IQ/OQ/PQ), sterilization management, logistics and warehousing, testing services, and master validation planning. The company works with major national and multinational pharmaceutical organizations and emphasizes customized solutions, hand assembly capabilities, special testing, and small-lot production flexibility. Rexmed maintains lean enterprise methodology with six sigma practices and is recognized as a socially responsible company (ESR) by the Mexican Center for Philanthropy. Distribution and logistics partnerships include Silan Medexo (import/export), Doniphan Logistics (distribution center), and PJ Technologies (infusion pump system distribution).

THE SURGICAL COMPANY INTERNATIONAL BV (TSC Life) is a global medical device manufacturer specializing in temperature management systems, fluid and blood warming devices, and single-use bronchoscopes for operating rooms, intensive care units, and emergency departments. The company's core product portfolio includes the Broncoflex® line of single-use bronchoscopes (including the XFlo variant with enhanced working channels for diagnostic and therapeutic procedures), Mistral-Air® forced-air warming systems, and Fluido® blood and fluid warming devices (Fluido Compact, Fluido AirGuard System, Fluido Irrigation). These solutions address patient safety through normothermia maintenance and cross-contamination prevention across surgical, critical care, emergency, and urological settings. TSC Life operates internationally from Amsterdam, The Netherlands, with US customer service and multiple distribution partners. The company emphasizes evidence-based design, infection control benefits through single-use construction, and workflow efficiency. Products serve pulmonologists, intensivists, anesthesiologists, and surgical teams in high-acuity environments including trauma, cardiac surgery, and complex oncology procedures. The company has received FDA clearance for pediatric use of the Fluido Compact system and maintains commitment to sustainable, accessible healthcare delivery with a target to reach 25 million patients annually.

Eigen Health is a California-founded medical technology company (established 1975) specializing in advanced MRI-ultrasound fusion systems and minimally invasive focal therapies for prostate cancer diagnosis and treatment. The company operates in 36+ countries, serving academic institutions, hospitals, and clinical practices globally. The Artemis platform is their flagship 3D semi-robotic prostate biopsy system featuring real-time organ tracking and prospective needle navigation with switchable transrectal and transperineal modules. It performs rigid and elastic registration of multimodal imaging (MRI, PET-CT, PSMA PET-MRI) to real-time ultrasound. The TPO (Transperineal Operative) module is purpose-built for transperineal approaches with integrated ultrasound capabilities. ProFuse CAD is their advanced radiology software for computer-assisted detection, real-time mpMRI analysis, and MRI data preparation for fusion guidance. The Cryo product combines MRI/ultrasound fusion-guided biopsy with cryoablation for minimally invasive, often outpatient prostate cancer treatment. The company reports supporting clinical outcomes for over 3,000,000 patients worldwide and maintains multiple patents in fusion imaging and needle guidance technology. ISO 13485 certified, indicating compliance with medical device quality management standards. The company emphasizes long-term partnerships with distributors and clinical institutions for seamless technology integration into practice and research.

NeurAxis, Inc. is a medical device company specializing in neuromodulation therapies for chronic and debilitating conditions, particularly disorders of the gut-brain interaction (DGBI). The company manufactures IB-Stim, an FDA-cleared, wearable percutaneous electrical nerve field stimulation (PENFS) device worn behind the ear for treating functional abdominal pain associated with irritable bowel syndrome (IBS) and functional dyspepsia (FD), including FD-related nausea symptoms. IB-Stim is indicated for patients 8 years and older and represents a drug-free, non-surgical alternative. The company has secured multiple payer coverage policies, Veterans Affairs Federal Supply Schedule contracts, and established permanent reimbursement pathways through AMA Category I CPT codes. NeurAxis is committed to improving patient outcomes and reducing suffering through innovation in neuromodulation technology.

Renalytix is an AI-enabled in vitro diagnostics company specializing in chronic kidney disease (CKD) management, particularly diabetic kidney disease (DKD). The company's flagship product, KidneyIntelX.dkd, combines proprietary AI algorithms with blood-based biomarker analysis, genetic data, and electronic health record integration to generate patient risk stratification scores for progressive kidney function decline. The test received FDA marketing authorization in Q2 2023 and Medicare coverage determination in June 2024. KidneyIntelX enables early identification of high-risk patients with type 2 diabetes and CKD stages 1-3b, allowing clinicians to optimize treatment targeting and resource allocation to slow or prevent disease progression. Renalytix operates CLIA-certified clinical laboratories and partners with major healthcare systems including Mount Sinai Health System, University of Michigan, and Singing River Health System. The company also provides biomarker discovery and drug development support services to pharmaceutical partners. With a focus on shifting kidney disease management from reactive treatment to proactive health optimization, Renalytix addresses a significant public health need affecting over 850 million people globally.

HR HealthCare is a family-owned medical equipment manufacturing company specializing in healthcare consumables and integrated support services for urology, continence care, skin health, and wound care. Based in York, Pennsylvania, with 51-200 employees operating across four continents, the company manufactures intermittent and indwelling catheters, male external catheters, catheter securement devices, medical lubricants (HR Lubricating Jelly and Surgilube), and ultrasound gels (EcoVue). HR HealthCare's proprietary Loop Care Platform streamlines urological care workflows and coordination. The company offers comprehensive Patient Services managing supply processing, insurance coordination, and delivery logistics. Their TruAdvance 4P Urological Solution provides standardized protocols, infection prevention frameworks, and practical learning tools for CAUTI reduction. HR HealthCare emphasizes quality, transparency, and patient-centered care through a unified ecosystem connecting healthcare professionals, patients, and caregivers.

Rocket Medical is a UK-based manufacturer of single-use medical devices with over 60 years of operational history. Founded in 1964 and incorporated as Rocket Medical PLC in 1996, the company specializes in innovative drainage solutions, women's health products, gastrointestinal care, and diagnostics. Key product lines include the Rocket IPC home drainage portfolio for managing pleural effusions and malignant ascites, chest drain bottles with underwater seal technology, catheters for reproductive medicine and hysterosalpingography (HSG), biopsy needles, and specialized endoscopic tools. The company operates globally, serving healthcare professionals in over 50 countries with a network of 100+ partners. ISO 13485 certified and fully compliant with CE, TGA, Canadian, and US FDA regulations, Rocket Medical combines rigorous quality assurance with patient-centered innovation. The organization employs approximately 106-110 personnel and continues to collaborate with leading clinicians to advance clinical outcomes.

InnovaQuartz LLC is a specialized manufacturer of laser fiber optics devices for endourology and surgical applications, headquartered in Phoenix, Arizona. With nearly 25 years of industry leadership, IQ designs and manufactures advanced laser fibers, connectors, and related optical components that set performance standards for urological procedures including laser lithotripsy (URS) and benign prostatic hyperplasia (BPH) treatment. The company pioneered numerous surgical innovations including the first tapered hermetically-fused laser connector (BlackHole™), shaped-output lithotripsy fibers, water-cooled side-fire fibers, and laser-polished bare fiber tips. Current product portfolio includes ProFlex™ LLF surgical fibers paired with Pulsar™ HPC technology for enhanced energy collimation, ProGuard™ sapphire-tipped fibers with burn-back resistance, and the Phoenix™ BPH laser generator. IQ also serves analytical instrumentation and optics industries with fused quartz and silica-based components. The company maintains extensive patent protections across its technology platforms and operates under ISO quality management systems.

Promaxo is a MedTech company specializing in compact, single-sided portable MRI systems and AI-driven technologies for interventional imaging and image-guided procedures. The company's flagship product is an office-based MRI platform that received FDA clearance in March 2021, enabling real-time MR-guided biopsies and cancer treatment in ambulatory settings without requiring dedicated MRI suites. Promaxo's system is designed for urologists and hospitals targeting prostate cancer diagnosis and treatment, featuring AI-driven tissue characterization with reported 77% cancer detection rates and 33% improvement in detecting clinically significant cancers versus standard of care. The system requires minimal facility upgrades and integrates seamlessly into existing clinical workflows, allowing concurrent clinic operations and interventional procedures. Founded in 2016 and backed by strategic investors including MicroPort and Zepp Health, Promaxo holds over 200 patents and is expanding applications to breast oncology and orthopedics. The company is led by CEO and Chairman Amit Vohra.

MediBeacon Inc. is a medical technology company specializing in fluorescent tracer agents and transdermal detection technology for non-invasive physiological monitoring. The company's proprietary platform enables real-time measurement and monitoring of vital organ function through biocompatible fluorescent agents that are sensed through the skin via transdermal optical sensors. Primary clinical focus areas include nephrology (kidney function assessment via transdermal GFR measurement), gastroenterology (gut barrier permeability assessment), ophthalmology (fluorescent angiography for retinal vasculature visualization), and surgical applications (intraoperative visualization and identification of anatomical structures). MediBeacon's Transdermal GFR (TGFR) System received FDA PMA approval (P230019) and CE Mark for human clinical use. The company serves leading academic medical centers, research institutes, contract research organizations (CROs), and pharmaceutical companies globally for both preclinical research and clinical applications. MediBeacon maintains offices in St. Louis, Missouri (USA), Mannheim, Germany, and partnerships in Greater China through Huadong Medicine Co., Ltd.

Laser Engineering designs, manufactures, sells, and services CO2 laser systems and accessories for multi-specialty surgical applications. The company specializes in sealed-tube CO2 laser technology, with over 30 years of industry experience. Their flagship Ultra MD CO2 Laser System is engineered for precision and reliability in neuro/spine, ENT, gynecology, urology, general, and plastic surgery disciplines. The sealed-tube design eliminates the need for external gas tank storage, reducing operational costs and complexity. Laser Engineering also manufactures the UltraLase CO2 Waveguide fiber line with HeNe aiming beams for enhanced surgical cutting precision at higher wattages. Complete accessory offerings include handpieces, micromanipulators, and sterilization-compatible components. The company provides comprehensive product support, training, and service capabilities to surgical facilities nationwide, emphasizing U.S. manufacturing and user-friendly interface design.

Emmy Medical manufactures CystoSure®, a patented diagnostic device that combines urinary catheter and cystoscope functionality for safe, efficient visualization of the female bladder and ureteral openings. The device features a novel pancake balloon and low-profile catheter tip enabling standardized placement and optimal trigonal ridge positioning for comprehensive bladder diagnostics. CystoSure® is designed for use in both operating room and office settings, reducing procedural time, instrument exchange, and infection risk while enabling single-visit diagnostic cystoscopy. Compatible with standard 2.9 mm hysteroscopes, the system streamlines urological evaluation without requiring complex cystoscopy trays.

KOELIS is a France-based medical technology company specializing in MRI-ultrasound fusion imaging solutions for prostate cancer diagnosis, biopsy, and treatment. The company develops the KOELIS Trinity® System, an integrated mobile fusion imaging platform that combines 3D ultrasound with advanced imaging technology to provide millimetric accuracy in needle guidance during prostate interventions. Core proprietary technologies include OBT Fusion® (organ-based tracking that records biopsy core locations), 3D Ultrasound with automatic compensation for prostate and patient movement, and the 2nd Look option for comprehensive lesion evaluation and active surveillance. KOELIS also offers PROMAP-FT software for needle-based therapy guidance and specialized ultrasound probes. Operating in over 30 countries across North America, Europe, and Asia, the company has enabled precision prostate care for over 350,000 patients worldwide. KOELIS collaborates with leading academic medical centers and hospitals to advance personalized prostate cancer management and aims to democratize access to fusion-guided biopsy technology.

Kane Biotech Inc. is a Canadian biotechnology company founded in 2001 and headquartered in Winnipeg, Manitoba, specializing in the research, development, and commercialization of anti-biofilm technologies for human and animal health applications. The company has developed a proprietary portfolio of 80+ patents focused on preventing and removing microbial biofilms, which represent a significant clinical challenge in wound care, surgical applications, and infection control. Kane Biotech's current commercial offerings include revyve® Antimicrobial Wound Gel and revyve® Antimicrobial Wound Gel Spray, both utilizing the company's patented coactiv+® technology in a thermo-reversible gel formulation designed for optimal wound healing environments. The products are accessible through US reimbursement channels. The company is actively developing additional therapeutic solutions including coactiv+® Antimicrobial Surgical Hydrogel, DispersinB® Hydrogel, DispersinB® Acne Cleanser, and revyve® Antimicrobial Skin and Wound Cleanser. Kane Biotech also markets companion animal oral care and dermatology products (bluestem™, StrixNB®, DermaKB™) through strategic partnerships, including an exclusive North American veterinary distribution agreement with Dechra Veterinary Products LLC. The company is publicly listed on the TSX Venture Exchange (symbol: KNE) and US OTC markets (symbol: KNBIF), pursuing a royalty-based revenue model through technology licensing.

Medispec Puerto Rico is a medical equipment distributor, rental, and service provider operating for over 10 years in the Caribbean region. The company specializes in supplying advanced diagnostic, surgical, and specialty medical equipment across multiple clinical disciplines including Ophthalmology, Radiology, Cardiology, Urology, Orthopedics, ENT, Neurosurgery, and Pain Management. Medispec maintains partnerships with leading global manufacturers (Zeiss, Genoray, Esaote, Canon, NSK, Nanosonics, and others) and offers comprehensive solutions covering diagnostic imaging systems, surgical microscopes, ultrasound equipment, sterilization systems, and clinical monitoring devices. The company emphasizes integrity, quality, and customer support through sales, equipment rental, and technical servicing for hospital systems and specialty practices throughout Puerto Rico.

Acquire Med LLC is a Utah-based medical device supplier with 25+ years of industry experience specializing in urology and minimally invasive surgical equipment. The company manufactures and distributes proprietary laser fiber systems, bipolar electrodes, and single-use flexible ureteroscopes for stone management and urological procedures. Key product lines include the Q Fiber (holmium laser fiber with round tip), Q Loop/Q Disc (bipolar electrodes), and advanced laser systems (holmium and thulium) featuring stone dusting and fiber dust technology. The company also offers single-use flexible ureteroscopes with proprietary Riveted Snake Bone Technology, available for purchase or rental through their Q Rent program. Beyond product sales, Acquire Med provides comprehensive maintenance and servicing of medical equipment, staff training programs, and inventory management solutions designed to optimize operational efficiency and reduce healthcare facility costs. The company distributes NeoMedic Products and maintains a focus on delivering both new and refurbished medical equipment to hospitals and surgical centers. Their service model emphasizes performance optimization and cost reduction for healthcare providers.

Caldera Medical is a U.S.-based medical device manufacturer headquartered in Westlake Village, California, specializing in minimally invasive surgical solutions for women's pelvic health. Founded in 2002, the company develops and markets innovative products for stress urinary incontinence (SUI), pelvic organ prolapse (POP), and hysteroscopic tissue removal. The company's product portfolio includes the Desara® Family for SUI treatment, the Vertessa® Family for POP repair, the Benesta Family for hysteroscopic procedures, and the Luminelle system launched in 2024 for advanced gynecological applications. Recognized as the fastest-growing women's health company for three consecutive years, Caldera Medical emphasizes surgeon collaboration, physician training, and clinical support. The company is committed to improving patient outcomes through durable, effective minimally invasive treatments while supporting a global humanitarian program aimed at reaching one million women with pelvic health education and treatment by 2027.

SurgiPros LLC manufactures and supplies a comprehensive range of surgical instruments for open, laparoscopic, and arthroscopic procedures. The company specializes in specialty surgical instrument sets across multiple clinical disciplines including general surgery, urology, orthopedic/neurosurgery, hand surgery, plastic surgery, cardiovascular surgery, ophthalmology, ENT, and obstetric/gynecologic surgery. Product lines include retractors (general, bookwalter-type, lap, ortho/neuro, cardiac, perineal, plastic, hand, and eye retractors), forceps and clamps, scissors and needleholders, graspers, arthroscopic instruments (Acufex and Arthrex-type punches), laparoscopic instruments, trocars and cannulas, tunnelers, suction instruments, and specialty instruments for urology (Ravini and urethroplasty instruments, GU instruments), ENT (sinus, throat, microlaryngeal, ear instruments), and obstetric procedures (speculums, curettes, dilators, sounds). The company also offers custom instrument fabrication services and provides instrument kits for specialized applications including VATS (video-assisted thoracic surgery). SurgiPros instruments are precision-engineered for demanding surgical environments and serve hospitals, surgical centers, and specialty practices nationwide. The extensive product portfolio indicates strong manufacturing capabilities and market presence in the surgical instrument supply sector.

Typenex Medical is a Chicago-based medical device and supply company founded in 2004, specializing in patient safety and blood management solutions for hospitals, clinics, and surgery centers. The company manufactures a comprehensive portfolio of medical devices and consumables including blood identification systems (Typenex Blood Bands, FinalCheck Recipient Safety System), blood collection and transfer devices, patient identification labels and bands, anesthesia and respiratory supplies, laboratory products, floor fluid management systems, pharmacy labeling solutions (ArmorRx alcohol-resistant labels), operating room accessories, labor and delivery supplies, postoperative care products, urology devices, and vein therapy laser systems. Additionally, Typenex offers viral testing collection supplies and histology/cytology products. With approximately 78 employees, the company serves healthcare facilities across North America and internationally, including agreements with Premier, Inc. and distribution in Germany, Italy, and South Africa. Typenex focuses on affordable, clinically-proven solutions that enhance both clinician workflows and patient outcomes.

Urethrotech Inc. manufactures the Urethral Catheterization Device (UCD®), an FDA 510(k)-cleared, CE-marked medical device designed to address difficult or failed male urethral catheterization. The UCD® is a ready-to-use, non-traumatic catheterization solution featuring an integrated hydrophilic Nitinol guidewire integrated into a standard 16F silicone 3-way Foley catheter. The guidewire is inserted first to safely bypass anatomical obstructions (such as enlarged prostate lobes) before catheter placement, then removed after successful catheterization. The device is indicated as a second-line option in emergency departments and other high-risk clinical settings where standard catheterization has failed or is anticipated to be difficult. Clinical evidence demonstrates significant reductions in referrals (100% to 17%), major complications (54% to 17%), and per-patient costs (50% reduction). The company holds ISO 13485:2016 certification and provides comprehensive clinical education including on-demand training videos, live demonstration sessions, and free e-learning courses on advanced male urethral catheterization. Urethrotech serves hospitals, emergency departments, and clinical settings across the US, offering procurement support, sample evaluation programs, and structured in-service education to ensure safe and appropriate device use by qualified healthcare professionals.

Vitacon US, LLC is the North American sales, service, and contract manufacturer for Vitacon AS (Trondheim, Norway). The company specializes in the design, development, and distribution of the VitaScan LT series—fully automatic USB ultrasound bladder scanners. The VitaScan LT portfolio includes models eVue, cVue, C5, and C6, which employ dual-plane, auto-rotating, and auto-tracking ultrasound technology to calculate bladder volume in real-time without requiring sonographer training. These portable instruments are marketed for long-term care, nursing homes, skilled nursing facilities, acute care, emergency departments, surgery centers, and urology clinics. Vitacon US provides comprehensive support including calibration services, warranty registration, RMA processing, and technical documentation. The company maintains both shipping and mailing addresses in Minnesota and operates an online store for product sales and quotations.

Image Diagnostics Inc. is a US manufacturer of surgical, interventional, and diagnostic imaging equipment. Based in Fitchburg, MA, the company designs and manufactures specialized procedure tables, video integration systems, surgical lighting, suspension systems, and radiation protection products for hospitals and surgical centers. Core product lines include: Interventional/Endovascular tables featuring 4-way float technology for vascular surgery and endovascular procedures; Spine & 3D imaging tables optimized for fluoroscopic imaging without motion artifact; Pain Management and Multi-Purpose tables for interventional pain procedures; Urology tables (100UC+ model) with motorized four-way travel, elevation, and Trendelenburg tilt; Video Integration Systems (ilex duo, SKilex, ilex 58) for hybrid OR visualization across all modalities; Surgical Lighting via exclusive US distribution of SIMEON surgical lights; Ceiling and Mobile Suspension Systems; and Compass Flex Radiation Protection products. The company serves interventional radiology, endovascular surgery, spine surgery, pain management, urology, and general OR markets. Manufacturing capabilities include design and fabrication of precision surgical furniture and medical devices. ISO 13485:2016 certified for quality management in the design and manufacture of surgical procedure tables and mobile video integration devices. Products are engineered for compatibility with fluoroscopic, ultrasound, and hybrid imaging environments.

Convatec is a global medical products and technologies company with over 10,000 employees operating in approximately 90 countries. The company specializes in chronic condition management with leading positions in four core care categories: Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. Product portfolio includes wound dressings and skin substitutes (InnovaMatrix®), ostomy pouches and barriers (Esteem Body™), continence care solutions including intermittent catheters (GentleCath™ with FeelClean Technology™), and infusion therapy products through the Unomedical subsidiary. The company manufactures and distributes products for infection prevention, treatment of hard-to-heal wounds, at-risk skin and ulcerated tissue, and management of debilitating chronic conditions. Convatec operates under FDA oversight and maintains compliance with applicable regulatory frameworks including Medicare coverage determinations and competitive bidding programs. The organization emphasizes patient outcomes, reduced care costs, and quality of life improvement for individuals managing chronic diseases across hospital, clinic, and home care settings.

Carbon Medical Technologies, Inc. (formerly Advanced UroScience, Inc.) designs and manufactures implantable and minimally invasive medical devices using proprietary pyrolytic carbon coating technology. Founded in 1994, CMT is one of only five organizations worldwide with a dedicated pyrolytic carbon coating facility. The company specializes in devices for urological and oncological applications, with over 25 years of clinical use across 55+ countries and treatment of more than 1.4 million patients. CMT's primary product portfolio includes Durasphere® (an injectable bulking agent for stress urinary incontinence treatment), BiomarC® fiducial and tissue markers for radiation therapy and breast lesion localization, BiomarC® Restore for post-lumpectomy guidance, and the newly launched InjecSURE® cystoscopic injection system with female-specific anatomical design for urethral injections. The company operates under ISO 13485 and cGMP-compliant quality systems, maintains a validated ISO Class 7 cleanroom, and provides contract manufacturing services including design consultation, materials expertise, cleanroom assembly, and regulatory guidance. CMT supports multiple sterilization methods and manages the full product lifecycle from development through final delivery, positioning itself as a specialized provider for minimally invasive urology and oncology procedures.

Profound Medical Inc. is a medical device company specializing in minimally invasive urological interventions. The company develops and markets the TULSA Procedure™ (Transurethral Ultrasound Ablation), an MRI-guided, incision-free ablative technology for prostate cancer and benign prostatic hyperplasia (BPH) treatment. The TULSA-PRO system uses real-time MRI temperature monitoring with closed-loop feedback control to deliver precise, targeted thermal ablation to prostate tissue while preserving quality of life outcomes including erectile function and urinary continence. Clinical evidence includes the CAPTAIN trial, a first-of-its-kind multi-center randomized controlled trial directly comparing TULSA to robotic radical prostatectomy, demonstrating statistically significant superiority in erectile function and continence preservation at six months. The technology supports flexible treatment planning with 360-degree targeting capability, enabling customizable ablation volumes for localized prostate cancer, radiorecurrent prostate cancer, BPH, and combined conditions. The TULSA Procedure is supported by 67+ peer-reviewed publications with durability data extending to five-year clinical outcomes. The system prioritizes patient safety through MRI guidance, real-time monitoring, and automated precision control to minimize complications. Profound Medical serves urology specialists and institutional healthcare providers, offering physician education through the PRO-Talk platform.

Boston Scientific Corporation is a global medical device manufacturer serving multiple clinical specialties including cardiology, urology, gastroenterology, interventional radiology, electrophysiology, neurology, pain management, vascular surgery, and structural heart disease. The company manufactures and distributes a broad portfolio of minimally invasive medical devices, including cardiac rhythm management systems, interventional cardiology devices, electrophysiology catheters and mapping systems, spinal cord stimulation systems for pain management, urological devices, endoscopy and visualization systems, defibrillators, and interventional oncology equipment. Boston Scientific operates a healthcare professional portal providing online training through EDUCARE, e-commerce ordering, reimbursement resources, and comprehensive customer support with specialty-specific representative contact networks. The organization serves hospitals, ambulatory surgery centers, and healthcare professionals across the United States through direct sales and support teams organized by medical specialty. Products undergo rigorous regulatory compliance (FDA 510(k), international certifications) and the company emphasizes quality assurance and product safety as core organizational values. Customer care is available via a dedicated U.S. customer service line, with extended business hours Monday–Friday.

MacroLux Medical Technology Co., Ltd. is a China-based manufacturer focused on endoscopic diagnosis and treatment solutions. The company specializes in the design and development of single-use electronic endoscope products for minimally invasive procedures across multiple clinical specialties. Primary product lines include flexible ureteroscopes (CoralView U Series), airway management endoscopes, gynecological endoscopes, and ENT endoscopes. The CoralView U Series features advanced capabilities including digital imaging, adjustable bending with BendForce Enhancement Technology, and various French sizes (7.5Fr and others) optimized for different anatomical access. MacroLux serves global healthcare markets and participates in major international medical conferences including EAU, ESGE, and MEDICA, indicating significant market presence in Europe and beyond. The company has secured Series B+ venture funding from B Capital as of January 2025, supporting continued global expansion. Manufacturing and distribution are based in Shenzhen, China. While specific regulatory certifications (FDA, CE, ISO) are not explicitly mentioned in the fetched content, the participation in European medical conferences suggests alignment with relevant regulatory requirements. The company emphasizes innovation in minimally invasive urology and women's health endoscopy.

Fellow Health Inc. is a CLIA-certified diagnostic laboratory specializing in mail-in semen analysis and reproductive health testing. The company provides clinical-grade semen analysis, vasectomy post-procedure testing, and sperm cryopreservation services to over 3,000 clinics, including urology and reproductive endocrinology practices. Fellow's proprietary testing methodology has been peer-reviewed and validated to deliver clinically accurate results comparable to fresh samples analyzed within one hour, with turnaround times under 2 business days from specimen receipt. The service addresses compliance barriers in post-vasectomy semen analysis testing, achieving 86% compliance rates—significantly higher than industry standards—by offering patients a convenient, privacy-preserving home-based collection option. Fellow operates a CLIA-certified (#05D2177822) and COLA-accredited (#31245) laboratory and has processed over 225,000 samples. The company conducts peer-reviewed research into male reproductive health factors and seminal fluid diagnostics, publishing in journals including Fertility and Sterility and Journal of Urology. Markets served include high-volume vasectomy providers, urologists, reproductive endocrinologists, and OB/GYNs. The testing platform is designed to reduce clinic call volume related to results communication and improve patient satisfaction (93% reported satisfaction).

Jiangsu Conod Medical Devices Co., Ltd. is a Chinese medical device manufacturer and supplier with approximately 20 years of export experience serving over 50 countries across the Americas, European Union, Japan, and developing markets in Asia, Africa, and Latin America. The company manufactures and distributes a broad portfolio of single-use medical consumables and devices across eight primary product categories: urology (catheters, drainage bags, catheterization trays, leg bags, urine meters), personal protective equipment (medical masks, surgical masks, face shields, isolation gowns, examination gloves), wound drainage systems (suction accessories, drainage devices, sputum suction kits), anesthesia and breathing supplies (anesthetic masks, aerosol trays), enteral feeding systems (feeding sets, feeding pumps), household emergency kits, nonwoven fabric materials, and specialty products (enema systems, fecal management collectors). The company operates vertically integrated capabilities including precision mold design and development, in-house injection molding (27 molding machines), third-party sterilization services (ETO sterilization with ISO 11135-2014 and ISO 13485-2016 certifications, FDA and Japanese FMA registration), and independent testing and detection center services. Conod holds Chinese medical device registration certificates and serves domestic and international hospital systems, clinical facilities, and distribution partners. The company emphasizes quality control, advanced manufacturing equipment, and customized product solutions aligned with international regulatory standards.

SpaceBander Corporation manufactures SpaceBander®, a non-surgical medical device for rubber band ligation treatment of internal hemorrhoids. The device enables quick, painless hemorrhoid removal in an office-based setting in less than two minutes, eliminating the need for surgical intervention or ineffective topical treatments. Rubber band ligation is recognized as the most widely utilized and effective treatment modality for symptomatic internal hemorrhoids. The SpaceBander® addresses a significant clinical need: approximately 60 million Americans annually experience hemorrhoid symptoms, with 75% of those using over-the-counter treatments reporting recurrence. The device serves gastroenterologists, colorectal surgeons, and primary care physicians offering outpatient hemorrhoid treatment. The company targets the substantial market of adults over 50, among whom nearly half experience hemorrhoidal disease. SpaceBander® provides a practical alternative to both conservative management (creams, ointments) and invasive surgical hemorrhoidectomy, positioning itself in the minimally invasive, office-based procedure space within colorectal and gastroenterological practice.

RX Sleeve manufactures FDA Class II-listed penis sleeves and erectile dysfunction support devices. The company specializes in premium, skin-safe silicone wearable medical devices designed to address erectile dysfunction, post-surgical complications, and sexual health challenges. Products include customizable penis sleeves in multiple girth sizes (3.75" to 6.0"), the Grip™ patented harness system, and accessories including lubricants and sizing guides. Materials are medical-grade, hypoallergenic silicone available in natural skin tones. RX Sleeve offers custom fabrication services and serves patients with ED from various etiologies including prostate cancer, diabetes, medication side effects, Peyronie's disease, and age-related changes. The company provides doctor and therapist partnerships, supports FSA/HSA purchase eligibility, comprehensive 1-year warranty coverage, and discreet shipping. With over 20 years of operational history, the founder's background in surgical device design informs manufacturing standards. Customer support available M–F 9 AM–5 PM.

International Medical Devices, Inc. (IMD) is a Beverly Hills-based medical device company established in 2013, specializing in cosmetic penile implant technology. The company develops and commercializes Himplant®, the first and only FDA-cleared cosmetic penile implant on the market, backed by over two decades of clinical research and four separate FDA 510(k) clearances since 2004. Himplant® is available in five sizes for anatomical customization and is designed for outpatient surgical procedures with established clinical protocols. IMD operates across multiple continents, including the United States, Colombia, Mexico, and Middle Eastern countries (UAE, Saudi Arabia, Qatar, Jordan, Turkey), with an extensive international patent portfolio. The company actively recruits distribution partners and maintains a trained surgeon network for procedure delivery. IMD serves three primary market segments: distribution partners seeking territorial expansion, surgeons and clinicians requiring training and clinical protocol support, and patients seeking the procedure. The company holds multiple FDA 510(k) clearances and maintains regulatory compliance across its operating regions. IMD provides comprehensive clinical data, product specifications, and partnership support through its corporate headquarters and online platforms.

Paragon Medical is a medical device manufacturing and component supplier specializing in end-to-end product development and precision manufacturing for medical OEMs. The company designs and manufactures precision components, surgical instrumentation, orthopedic implants, drug delivery systems, and single-use disposable devices across multiple surgical specialties including orthopaedics, cardiovascular, surgical robotics, dental, endoscopy, laparoscopy, and gastroenterology. Paragon operates FDA-registered manufacturing facilities with ISO 8 Class 100,000 certified cleanrooms for medical-grade packaging and labeling. The company provides comprehensive services spanning concept development, design control, regulatory affairs and FDA submissions, verification and validation testing, manufacturing scale-up, and commercialization support. Manufacturing capabilities include precision machining, additive manufacturing, and assembly of components from surgical materials, specialty alloys, and plastics in volumes ranging from prototype quantities to multi-million unit production runs. Paragon serves medical device manufacturers requiring contract manufacturing, OEM partnerships, and integrated new product development support. The company emphasizes vertical supply chain integration and functions as an extension of client in-house development teams.

Artisan Medical Devices is a surgical instruments and medical devices supplier based in Medford, New Jersey, serving hospitals, surgery centers, and physician offices throughout the United States and internationally for over 15 years. The company specializes in surgical instrumentation across multiple specialties including laparoscopic surgery, OB/GYN, general surgery, urology, colorectal surgery, and spinal procedures. Product lines include laparoscopic instruments, electrosurgical forceps, table-mounted and lighted hand-held retractors, spinal retractor systems, and specialty instruments for obstetrics, gynecology, urological, and general surgical applications. The company maintains a B2B e-commerce platform with request-for-quote capability and offers shipping domestically and internationally. Artisan Medical positions itself as a direct supplier to surgical facilities, offering product sourcing and procurement solutions for operating room and surgical practice needs.

Zida LLC manufactures the Zida Control Sock, a FDA-cleared neuromodulation device for at-home treatment of overactive bladder (OAB) and associated urinary symptoms including urge incontinence, urinary frequency, and nocturia. The device uses patented embedded nano-electronics to deliver percutaneous tibial nerve stimulation (PTNS), accessing the tibial nerve at the ankle region to modulate sacral nerve function and regulate bladder control. Clinical data demonstrates over 70% reduction in incontinence episodes. Treatment protocol requires 12 sessions administered once weekly for 30 minutes each. The device is unisex, non-invasive, has no serious side effects, and requires no drug interactions. Zida products are prescribed through US physicians and covered by major insurers including Medicare, Cigna, and Blue Cross. The company serves urology practices, continence clinics, and patients across all age groups seeking non-pharmacological, non-surgical bladder dysfunction management.

Avation Medical develops and commercializes Vivally®, an FDA-cleared wearable at-home treatment system for overactive bladder (OAB) symptoms, including urgency urinary incontinence and frequency. The Vivally System combines a wearable ankle wrap, a wireless CliQ™ control module, and a mobile application to deliver physiologic closed-loop controlled transcutaneous tibial nerve stimulation (PCL TTNS) with continuous EMG sensing. The treatment regimen consists of 30-minute sessions administered three times weekly, allowing patients to manage therapy on their own schedule at home. Clinical evidence from multicenter prospective trials demonstrates that 84% of enrolled patients were responders experiencing significant improvement in OAB symptoms and quality of life, with sustained reductions in void, incontinence, and urgency episodes observed through 12 months of use. The system features high patient satisfaction rates and no significant device-related adverse events. Vivally targets a large addressable market: approximately 42 million Americans suffer from OAB and urge urinary incontinence. The platform supports remote monitoring and digital health capabilities, enabling providers to prescribe and calibrate therapy during a single office visit, then track patient progress remotely. Avation Medical provides comprehensive patient support including coverage coordination with major commercial payors, customer care services, and claims and billing assistance. The company markets the system to both patients seeking non-pharmacological OAB management and healthcare providers seeking to offer advanced therapeutic options.